News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2025 Caitlin E. Cox December 01, 2025
News Conference News AHA 2025 Anticoagulation Alone Is Best in AF Patients a Year or More Out From PCI Todd Neale November 09, 2025
News Daily News Low Bleeding Risk With Abelacimab in AF Patients Undergoing Invasive Procedures Todd Neale June 10, 2025
News Conference News HRS 2025 VANISH2 Bolsters Data Backing VT Ablation in Ischemic Cardiomyopathy Todd Neale April 29, 2025
News Daily News Low Bleeding Profile With Asundexian Seen in Pooled Analysis L.A. McKeown February 13, 2024
News Conference News AHA 2023 NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear L.A. McKeown November 12, 2023
News Daily News ‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF L.A. McKeown September 18, 2023
News Conference News EHRA 2023 Novel Score Identifies HF Patients With AF Who Respond to Ablation Michael O'Riordan April 19, 2023
News Conference News AHA 2022 Botulinum Toxin Injections No Help for Postoperative AF: NOVA Yael L. Maxwell November 07, 2022
News Daily News VITAL Rhythm Data May Flip the Script on AF Screening in Women L.A. McKeown September 08, 2022
News Conference News ESC 2022 ESC Revamps Guidelines on Ventricular Arrhythmias, Sudden Cardiac Death Todd Neale September 02, 2022
News Opinion Editor's Corner ESC 2022 What’s Going to Be Hot at ESC 2022? Shelley Wood August 22, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for June 2022 Caitlin E. Cox July 04, 2022
News Daily News Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study Todd Neale December 27, 2021
News Conference News ESC 2021 OAC Analysis From MASTER DAPT Raises No Red Flags for Shorter DAPT Shelley Wood September 02, 2021
News Daily News VITAL RHYTHM in Print: Dose Effects of Omega-3s on AF Still Unclear Shelley Wood March 17, 2021